ACLARUBICIN HYDROCHLORIDE
- CAS NO.:75443-99-1
- Empirical Formula: C42H54ClNO15
- Molecular Weight: 848.33
- MDL number: MFCD00133024
- EINECS: 278-209-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-05-27 23:58:51
What is ACLARUBICIN HYDROCHLORIDE?
Definition
ChEBI: Aclarubicin hydrochloride is an anthracycline.
Biological Activity
Aclacinomycin A hydrochloride (Aclarubicin hydrochloride) is a fluorescent molecule and the first non-peptidic inhibitor discovered to have discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. It is also a dual inhibitor of topoisomerase I and II (topoisomerase I and II). It is an effective anthracycline chemotherapeutic agent for blood cancer and solid tumor related research.
in vitro
Aclacinomycin A could efficiently enter living cells and emit fluorescence in situ . Aclacinomycin A (10 μM for 15 min) is sufficient for clear detection of fluorescence in most of the cultured cells. Aclacinomycin A treatment (10 μM Acla for 15 min) results in approximately 20% dead (or nearly dead) cells.
Aclacinomycin A (Aclarubicin) effectively induces incorporation of exon 7 into SMN2 transcripts from the endogenous gene in type I SMA fibroblasts as well as into transcripts from a SMN2 minigene in the motor neuron cell line NSC34 .
in vivo
Aclarubicin hydrochloride(Aclacinomycin A) is very well absorbed in mice, rats, and dogs after its oral administration. The oral LD 50 (76.5 mg/kg) is about twice the iv LD 50 (35.6 mg/kg) in mice [4 .
Aclacinomycin A ( 0.75-6 mg/kg, ip daily) dose-dependently exhibits tumor growth in mice-based Leukemia P-388 model [4 .
| Animal Model: | DBA/2, CDF 1 ( BALB/c×DBA/2) mice with Leukemia P-388 [4 . | tr>
| Dosage: | 0.75 mg/kg, 1.5 mg/kg, 3 mg/kg, 6 mg/kg. | td>
| Administration: | Intraperit oneal administration daily for 10 days starting 3 hr after transplantation. |
| Result: | Inhibited tumor growth. |
Properties of ACLARUBICIN HYDROCHLORIDE
| Melting point: | 151-153℃ |
| Boiling point: | 898℃ |
| Flash point: | >110°(230°F) |
| storage temp. | 2-8°C |
| solubility | Soluble in DMSO or DMF at 25mg/ml |
| form | Solid |
| color | Light yellow to yellow |
Safety information for ACLARUBICIN HYDROCHLORIDE
| Pictogram(s) |
![]() Skull and Crossbones Acute Toxicity GHS06 |
| GHS Hazard Statements |
H301:Acute toxicity,oral H311:Acute toxicity,dermal H331:Acute toxicity,inhalation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P405:Store locked up. |
Computed Descriptors for ACLARUBICIN HYDROCHLORIDE
New Products
Dibenzoyl-L-tartaric acid Anhydrous (Resolution Reagent) 2-Bromo-5-hydroxybenzoic acid. 1-(4-methoxyphenyl)-4-(4-Nitrophenyl)Piperazine (IT-1) 4-Fluorophenylglycine 1-N-Boc-3-(aminoethyl)azetidine Dimedone 1-Boc-3-(cyanomethyl)azetidine N-BOC-piperidine-4-carboxylic acid 1-Benzhydrylazetane-3-carbonitrile 5-Amino-2-Hydroxypyridine 2-Amino-5-Iodopyridine 2-BROMOACETYL BROMIDE-D2 METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR BENZENE-D6 TOLUENE-D3 6-Chloro-pyrimidine-2,4-diamine 3-Oxide 1-Acetyl-4-(4-hydroxyphenyl)piperazine 1-(3-Chlorophenyl)piperazine hydrochlorideRelated products of tetrahydrofuran








You may like
-
350-03-8 3-AcetylpyridineView Details
350-03-8 -
1-(4-Aminophenyl)-4-(4-methoxyphenyl)Piperazine 74852-62-3View Details
74852-62-3 -
556-08-1 4-Acetamidobenzoic acidView Details
556-08-1 -
5-Bromo-2-Chlorobenzoic acid 21739-92-4View Details
21739-92-4 -
15128-52-6View Details
15128-52-6 -
36476-86-5 1-Benzhydrylazetane-3-carbonitrile 98+View Details
36476-86-5 -
36476-86-5 1-Benzhydrylazetane-3-carbonitrile 98+View Details
36476-86-5 -
36476-86-5 1-Benzhydrylazetane-3-carbonitrile 98+View Details
36476-86-5

